Octagon Biotech Opportunities Fund II LP — Form D

Octagon Biotech Opportunities Fund II LP of NEW YORK, NY, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2026-07-02. The offering totals $175.0M, of which $17.8M was reported sold. Industry: Pooled Investment Fund.

Offering

• Filed: 2026-07-02
• Form: D
• Accession: 0002132995-26-000002
• Industry: Pooled Investment Fund
• Exemptions: 06b,3C,3C.7
• Total offering: $175.0M
• Amount sold: $17.8M
• Remaining: $157.2M
• Minimum investment: $5.0M
• Investors: 5
• Security types: fund interests
• Revenue range: Decline to Disclose
• SEC file number: 021-589489

Issuer

• Name: Octagon Biotech Opportunities Fund II LP
• CIK: 0002132995
• Entity type: Limited Partnership
• Jurisdiction: DELAWARE
• Address: 654 MADISON AVENUE, FL. 21, NEW YORK, NY, 10065
• Phone: 212-369-2829

Officers, directors & promoters (1)

More

• CIK 2132995 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search